gp130: a promising drug target for cancer therapy
Author:
Publisher
Informa Healthcare
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14728222.2013.830105
Reference223 articles.
1. Hallmarks of Cancer: The Next Generation
2. Activated human T lymphocytes display new surface glycoproteins.
3. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
4. Molecular cloning and expression of an IL-6 signal transducer, gp130
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identification of two novel variants in ALG11 causing congenital disorder of glycosylation;Seizure: European Journal of Epilepsy;2024-10
2. The role of interleukin‐6 family cytokines in cancer cachexia;The FEBS Journal;2024-07-08
3. ART1 knockdown decreases the IL-6-induced proliferation of colorectal cancer cells;BMC Cancer;2024-03-19
4. An in-silico scaffold- hopping approach to design novel inhibitors against gp130: A potential therapeutic application in cancer and Covid-19;Molecular Diversity;2023-11-07
5. Tumor cell-derived exosomes regulate macrophage polarization: Emerging directions in the study of tumor genesis and development;Heliyon;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3